Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling

Cardiovascular Research

Volumn 81, Issue 3, 2009, Pages 565-573

  Kohno, Takashi ^a   Anzai, Toshihisa ^a   Naito, Kotaro ^a   Miyasho, Taku ^b   Okamoto, Minoru ^b   Yokota, Hiroshi ^b   Yamada, Shingo ^c   Maekawa, Yuichiro ^a   Takahashi, Toshiyuki ^a   Yoshikawa, Tsutomu ^a   Ishizaka, Akitoshi ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

^c SHINO TEST CORPORATION   (Japan)

Author keywords

Cytokines; Heart failure; Infarction; Infection inflammation; Remodelling

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART RUPTURE; HEART VENTRICLE REMODELING; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ST SEGMENT ELEVATION; TISSUE REPAIR; WISTAR RAT;

AGED; ANGINA PECTORIS; ANIMALS; ANTIBODIES; C-REACTIVE PROTEIN; CREATINE KINASE; DISEASE MODELS, ANIMAL; FEMALE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VENTRICULAR REMODELING; WOUND HEALING;

EID: 59449099249     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn291     Document Type: Article

References (38)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
3. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-1553.
4. Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005;66:22-32.
5. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998;98:149-156.
6. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-5246.
7. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
8. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
9. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-570.
10. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
11. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004;170:1310-1316.
12. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Ebina M et al. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 2006;30:1755-1762.
13. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976;53:I204- I206.
14. Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983;68:446-452.
15. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004;110:3221-3228.
16. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;104:826-831.
17. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 2003;49:1535-1537.
18. Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y et al. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med 1998;338:941-947.
19. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
20. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol 2002;39:241-246.
21. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2004;44:1510-1520.
22. Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005;65:446-456.
23. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005;288:L958-L965.
24. Hassl A, Aspock H. Purification of egg yolk immunoglobulins. A two-step procedure using hydrophobic interaction chromatography and gel filtration. J Immunol Methods 1988;110:225-228.
25. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978;90:57-70.
26. Alhaddad IA, Tkaczevski L, Siddiqui F, Mir R, Brown EJ Jr. Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. Circulation 1995;91:2819-2823.
27. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-1143.
28. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006;26:6413-6421.
29. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-1418.
30. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007;170:818-829.
31. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008;128:1545-1553.
32. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005;97:e73-e83.
33. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007;100:204-212.
34. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40-46.
35. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005;96:881- 889.
36. Nathan C. Points of control in inflammation. Nature 2002;420:846-852.
37. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008;117:3216-3226.
38. Takahashi M. High-mobility group box 1 protein (HMGB1) in ischemic heart disease: beneficial or deleterious? Cardiovasc Res 2008;80:5-6.